In the case of mir-200b~429 cluster, promoter methylation was confirmed in HCC, resulting in miR-200b downregulation, ZEB1 upregulation, and CD13 and CD24 expression. The gene discussed is ZEB1; the disease is hepatocellular carcinoma.